Thermo Fisher Scientific Inc. (ETR:TN8)

Market Cap	178.83B
Revenue (ttm)	41.42B
Net Income (ttm)	6.12B
Shares Out	n/a
EPS (ttm)	15.97
PE Ratio	29.23
Forward PE	n/a
Dividend	1.48 (0.31%)
Ex-Dividend Date	Mar 14, 2025

Volume	9
Average Volume	205
Open	473.70
Previous Close	475.55
Day's Range	473.25 - 475.55
52-Week Range	466.65 - 590.90
Beta	n/a
RSI	33.46
Earnings Date	Apr 23, 2025

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1956
• Employees: 125,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: TN8

Financial Performance

In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.

Financial numbers in USD